Abstract

Ferroptosis is a regulated cell death due to the iron-dependent accumulation of lipid peroxide. Ferroptosis is known to constitute the pathology of ischemic diseases, neurodegenerative diseases, and steatohepatitis and also works as a suppressing mechanism against cancer. However, how ferroptotic cells affect surrounding cells remains elusive. We herein report the transfer phenomenon of lipid peroxidation and cell death from ferroptotic cells to nearby cells that are not exposed to ferroptotic inducers (FINs). While primary mouse embryonic fibroblasts (MEFs) and NIH3T3 cells contained senescence-associated β-galactosidase (SA-β-gal)-positive cells, they were decreased upon induction of ferroptosis with FINs. The SA-β-gal decrease was inhibited by ferroptotic inhibitors and knockdown of Atg7, pointing to the involvement of lipid peroxidation and activated autophagosome formation during ferroptosis. A transfer of cell culture medium of cells treated with FINs, type 1 or 2, caused the reduction in SA-β-gal-positive cells in recipient cells that had not been exposed to FINs. Real-time imaging of Kusabira Orange-marked reporter MEFs cocultured with ferroptotic cells showed the generation of lipid peroxide and deaths of the reporter cells. These results indicate that lipid peroxidation and its aftereffects propagate from ferroptotic cells to surrounding cells, even when the surrounding cells are not exposed to FINs. Ferroptotic cells are not merely dying cells but also work as signal transmitters inducing a chain of further ferroptosis.

Details

Title
Lipid peroxidation and the subsequent cell death transmitting from ferroptotic cells to neighboring cells
Author
Nishizawa Hironari 1   VIAFID ORCID Logo  ; Matsumoto Mitsuyo 2 ; Chen, Guan 3 ; Ishii Yusho 4 ; Tada Keisuke 5 ; Onodera Masafumi 6 ; Kato Hiroki 7   VIAFID ORCID Logo  ; Muto Akihiko 1 ; Tanaka, Kozo 3   VIAFID ORCID Logo  ; Igarashi Kazuhiko 2   VIAFID ORCID Logo 

 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Center for Regulatory Epigenome and Diseases, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
 Tohoku University, Department of Molecular Oncology, Institute of Development, Aging and Cancer, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Department of Hematology and Rheumatology, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Emory University, Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502) 
 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Department of Pediatric Surgery, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
 National Research Institute for Child Health and Development, Department of Human Genetics, Tokyo, Japan (GRID:grid.63906.3a) (ISNI:0000 0004 0377 2305) 
 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Department of Hematology and Rheumatology, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
Publication year
2021
Publication date
Mar 2021
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2506709261
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.